Sutro Biopharma, Inc. (STRO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Sutro Biopharma, Inc. (STRO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $336.5M, listed on NASDAQ, employing roughly 269 people, carrying a beta of 1.64 to the broader market. Sutro Biopharma, Inc. Led by Jane Chung, public since 2018-09-27.
Snapshot as of May 15, 2026.
- Spot Price
- $39.78
- Total OI
- 811